AUS
NZ
UK
CA
USA
IND
Healthcare
ImpediMed Announces Update on Quarterly Results and Investor Conference Call Details
April 24, 2019 03:52 PM AEST| By Team Kalkine MediaA world leader in the design and manufacturing of medical devices, ImpediMed Limited (ASX: IPD) today, on 24th April 2019 announced that it will release Quarterly Cash Flow Report for the period ending 31 March 2019, on Tuesday, 30th April 2019. Inte...
Actinogen Medical releases its March Quarterly results
April 24, 2019 02:16 PM AEST| By Team Kalkine MediaBiotechnology company, Actinogen Medical Limited (ASX: ACW) on 24 April 2019, released its quarterly update report for the three months period ending on 31 March 2019. On the operational front, the company had notified the market in February 2019 ab...
Elixinol Global To Acquire 25.43% Stake In Altmed Pets LLC
April 24, 2019 01:46 PM AEST| By Team Kalkine MediaElixinol Global Limited (ASX: EXL) is in the healthcare industry based in Sydney, Australia. The company has a global presence in the cannabis industry and manufacture products like hemp food and wellness products, hemp-derived CBD dietary supplement...
Pro Medicus Signed a 7-year contract with Leading U.S. Academic Medical Center
April 24, 2019 12:41 PM AEST| By Team Kalkine MediaLeading medical imaging IT provider, Pro Medicus Limited (ASX: PME) has taken a significant step in further implementing its Visage 7 technology across different academic and research-oriented clients. In an announcement made on Wednesday, 24 April 2...
Chinese Regulator Approves Oscar 2 With SphygmoCor® Inside ABPM
April 23, 2019 09:33 PM AEST| By Team Kalkine MediaCardieX Limited (ASX: CDX), a global health technology company which is headquartered at Victoria Road, West Ryde NSW, Australia. The company deals in the development of technology solutions for large-scale population health disorders. The Chinese F...
Noxopharm Announces Changes In Its Board Structure
April 23, 2019 02:57 PM AEST| By Team Kalkine MediaAustralian drug development company, Noxopharm Limited (ASX: NOX) has started the process of raising its profile and presence in the U.S. including a listing of its securities on the Nasdaq exchange. Driven by this strategic decision, the company has...
ResApp’s Shares Zoomed Up On ASX After Announcing Positive Results From Its Australian Adult Clinical Study
April 23, 2019 01:20 PM AEST| By Team Kalkine MediaLeading digital health company, ResApp Health Limited (ASX: RAP) has announced positive top-line results from its Australian Breathe Easy adult prospective, double-blind clinical study. Following the release of this news, the share price of the compa...
Will This Healthcare Stock Retain Its Upward Momentum – VHT?
April 20, 2019 08:30 AM AEST| By Team Kalkine MediaHealthcare sector company, Volpara Health Technologies Limited (ASX: VHT) is trading near to its 52-week high of $1.900 with the stock up 70.45% this year. All the recent news has favoured the company to such an extent that it took the annual yield...
Two Cancer Fighting Stocks That Plunged This Year – OSL, PAB
April 19, 2019 08:30 AM AEST| By Team Kalkine Media?OncoSil Medical Ltd OncoSil Medical Ltd (ASX: OSL) is a medical product company, which is working on improving the radiation procedure for cancer patients. The Company?s lead product, OncoSil? is set directly into a patient?s affected pancreatic tu...
Analytica Limited’s PeriCoach® Is Now CE-Mark For Treatment Of Pelvic Organ Prolapse
April 18, 2019 07:37 PM AEST| By Team Kalkine MediaAnalytica Limited (ASX: ALT) is a medical device company whose lead product is the PeriCoach? System, an e-health treatment system for women who suffer Stress Urinary Incontinence.? The company believes that PeriCoach is the only smartphone pelvic fl...
Creso Pharma receives regulatory clearance from ANVISA to import cannaQIX® 50 into Brazil
April 18, 2019 02:45 PM AEST| By Team Kalkine MediaCreso Pharma Limited (ASX: CPH) is a healthcare company which has a primary interest in the medical cannabis sector. It aims to improve the lives of humans as well as animals by developing and manufacturing highest quality products through pharmaceut...
Paradigm Pharmaceuticals Raises Capital Via Placement And Institutional Entitlement Offer
April 18, 2019 01:10 PM AEST| By Team Kalkine MediaParadigm Pharmaceuticals Limited (ASX: PAR) is a biotechnology company based in Australia. It is focused on repurposing Pentosan Polysulfate Sodium (PPS) which is an FDA approved drug which is used for safely treating inflammation and dissolving bloo...
THC Provides Update on Global Hydroponic Equipment Operations and Release of Securities from Escrow
April 18, 2019 01:07 PM AEST| By Team Kalkine MediaTHC Global Group Limited (ASX: THC) is a small cap Australian company that deals in delivery of high quality medicinal cannabis products to Australian patients and the export market. The company was officially listed on 4th May 2017 on ASX. The compa...
What Led To A 23% Jump In Share Price Of MGC Pharmaceuticals Ltd Today?
April 17, 2019 06:37 PM AEST| By Team Kalkine MediaOn 17th April 2019, MGC Pharmaceuticals Ltd (ASX: MXC) has signed an agreement with Chinese e-commerce import platform YuShop Global (YuShop) to market and distribute its nutraceuticals CBD based products in the Chinese health products market. Market...
Thumbs Up to Noxopharm’s New Immuno-Oncology Drug Idronoxil
April 17, 2019 03:52 PM AEST| By Team Kalkine MediaNoxopharm Limited (ASX: NOX) is a clinical-stage Australian drug development company primarily focussing on the development of drugs based on a phenolic chemical structure, with the company?s first pipeline product, Veyonda? . Noxopharm has identifi...
Cochlear’s Shares Rose 7.8% On ASX Post Announcement of Nucleus® Profile Launch
April 16, 2019 09:18 PM AEST| By Team Kalkine MediaCochlear Limited (ASX:COH) is in the healthcare sector with its operations in innovating and presenting the market with a spectrum of implantable hearing solutions that deliver a lifetime of hearing outcomes. The launch of the Nucleus? Profile? Plus...
Imugene Limited Provided Quarterly Cash Flow Report For March Quarter
April 16, 2019 06:17 PM AEST| By Team Kalkine MediaBiotechnology company, Imugene Limited (ASX: IMU) is an emerging leader in cancer immuno-oncology which has made significant progress in the recent past. Today, the company has announced its quarterly cash flow report for the quarter ended 31 March 2...
HeraMed collaborates with Meerkats for Australian B2C launch
April 16, 2019 05:18 PM AEST| By Team Kalkine MediaHeraMed Limited (ASX: HMD) is a medical technology company that develops and sells pregnancy monitoring solutions in Australia, Europe, and Israel. On April 16th, 2019, the company announced to have entered into a partnership with Australian creative...
Starpharma Holdings’ Shares Surged Over 7% On ASX Post First VivaGel BV Launch Announcement
April 16, 2019 02:40 PM AEST| By Team Kalkine MediaStarpharma Holdings Limited (ASX: SPL) announced that they have successfully launched VivaGel? BV (an Australian innovation) in Australia through Aspen Pharmacare (Aspen) as Fleurstat BVgel. This is the first launch and distribution of product across...
Osprey’s Shares Climbed up on ASX As DyeVert First Quarter Unit Sales Grew by 73%
April 16, 2019 02:21 PM AEST| By Team Kalkine MediaOsprey Medical Inc. (ASX: OSP) has a mission to improve outcomes in chronic kidney disease patients by reducing contrast-induced acute kidney injury and lowering hospital costs. It is a commercial stage company under the health care sector. The comp...
Advertise your brand on Kalkine Media